Biotech

All Articles

Basilea credit ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work developing new antifungals has actually received a considerable boost ...

Capricor sells Europe civil liberties to late-stage DMD therapy for $35M

.Possessing actually scooped up the U.S. rights to Capricor Therapeutics' late-stage Duchenne muscul...

FDA scraps adcomm for Applied's unusual ailment drug

.After dismissing the selection meeting for Applied Therapeutics' metabolic disorder medication govo...

Novo inks $600M NanoVation bargain to examine hereditary medicines ex-liver

.Novo Nordisk is continuing its own push into hereditary medications, accepting to pay NanoVation Th...

Innovent hyperlinks cytokine to colon cancer cells feedbacks

.Innovent Biologics has helped make the instance that its gate inhibitor-cytokine combination protei...

Merck, Daiichi ADC hits objective in stage 3 bronchi cancer research

.A stage 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina strengthens artificial intelligence focus with collab to choose cancer cells targets

.5 months after Rakovina Therapies turned towards artificial intelligence, the cancer-focused biotec...

Ascendis' dwarfism medicine smash hits in stage 3, threatens BioMarin

.Ascendis Pharma has actually emerged as a possible danger to BioMarin's Voxzogo, reporting phase 3 ...

Despite ph. 3 skip, Alkeus finds course ahead of time for eye ailment possession

.Though Alkeus Pharmaceuticals' dental eye ailment possession stopped working to dramatically minimi...

Kairos goes social along with $6M IPO to money trials of cancer cells medication

.Along with a trio of biotechs hitting the Nasdaq on Friday, it was simple to skip a smaller-scale s...